Article
06 Nov 2025
FDA Proposes To Eliminate Comparative Clinical Efficiency Studies For Biosimilars
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
12 Sep 2025
DTC Reforms And MAHA Proclamations: The MAHA Agenda And Its Focus On Prescription Drugs Continues To Take Shape
Article
11 Sep 2025
Transparency So Radical It Overlooks Law And Tradition: FDA Releases Complete Response Letters For Unapproved Drugs
Article
25 Aug 2025
The Demise Of FDA's Administrative Summary Judgment Standard: Lessons From Vanda v. FDA
Article
13 Aug 2025
Continued Efforts To Onshore Pharmaceutical Manufacturing: FDA Announces New FDA PreCheck Program
Article
08 Aug 2025
Implications Of FDA's "Radical Transparency" Plan For Complete Response Letters
Article
29 Jul 2025
FDA Begins To Accept Nominations For The Commissioner's National Priority Voucher Pilot Program
Article
23 Jun 2025
FDA Announces Commissioner's National Priority Vouchers To Facilitate Expedited Access To Certain Drugs
Article
20 May 2025
Former FDA Officials Howard Sklamberg And Eva Temkin Share Insights On AI's Role In Drug Development On FDA Watch Podcast
Article
14 May 2025
President Trump Issues Executive Order On Regulatory Relief To Promote Domestic Production Of Critical Medicines
Article
22 Apr 2025
Trump Administration Issues Executive Order To Lower Prescription Drug Costs
Article
21 Apr 2025
Trump Administration Takes Next Steps Toward Pharmaceutical Tariffs
Article
04 Apr 2025
LDTs Are Not Devices Under The FDCA: Eastern District Of Texas Vacates FDA Final Rule On LDTs
Article
20 Feb 2025
A First Look At The MAHA Era: Initial Thoughts For Industry Based On The MAHA Commission EO
Article
18 Feb 2025
The DOGE Workforce Optimization EO: Implications For FDA
Article
03 Feb 2025
Late Guidance Push By Biden Administration Over Clinical Trial Diversity Faces New Obstacles From Recent Trump Executive Orders
Article
30 Jan 2025
FDA Finalizes Rule On ACNU Drugs, Signaling Opening For Next-Gen OTC Drugs
Article
16 Jan 2025
FDA Issues New Draft Guidance On Getting Confirmatory Trials "Underway" For Accelerated Approvals
Article
16 Jan 2025
FDA Finalizes Its SIUU Guidance: An Analysis Of The Key Changes From The 2023 Draft Guidance
Article
27 Dec 2024
Recent SEC Case Against Biotech Company Highlights The Intersection Between FDA Findings And SEC Enforcement